THE University of Sydney has launched a new Drug Discovery Initiative, aiming to "unite researchers, clinicians and industry to develop promising drugs and delivery methods to improve human health".
The program will focus on early stages of the drug discovery pipeline -- infectious diseases, cancer therapies, inflammation, neurodegenerative and central nervous system disorders, and metabolic diseases - sydney.edu.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 12 Sep 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 12 Sep 18
